The Antibody Drug Conjugate (ADC) Development market is a subset of the biotechnology industry that focuses on the development of drugs that combine the targeting capabilities of antibodies with the therapeutic effects of small molecules. ADCs are designed to deliver a drug directly to a specific target, such as a tumor, while minimizing the drug's effect on healthy cells. This approach has the potential to improve the efficacy and safety of cancer treatments. ADC development involves a complex process that includes the selection of an appropriate antibody, the design of a linker to attach the drug to the antibody, and the selection of a drug payload. The process also requires the development of a manufacturing process to ensure the quality and consistency of the ADC. The ADC Development market is highly competitive, with a number of companies offering products and services. Examples include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
